Article
PCR-detection of tumor-derived p53 DNA in cerebrospinal fluid.
American journal of clinical pathology - 1 Apr 1995
Rhodes C H, Honsinger C, Sorenson G D
Abstract excerpt
The sensitivity of polymerase chain reaction (PCR)-based methods for the detection of DNA offers opportunities for tumor diagnosis from the small amounts of tumor-derived DNA released into body fluids. Tumor-derived DNA can be distinguished from DNA derived from non-neoplastic cells by the presence of tumor specific genomic alterations, such as mutations in the p53 gene. This case report describes the use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
